PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.53%
Revenue growth at 50-75% of AR's 9.77%. Martin Whitman would worry about competitiveness or product relevance.
-16.61%
Negative gross profit growth while AR is at 30.26%. Joel Greenblatt would examine cost competitiveness or demand decline.
80.51%
EBIT growth 50-75% of AR's 147.53%. Martin Whitman would suspect suboptimal resource allocation.
80.51%
Operating income growth at 50-75% of AR's 147.53%. Martin Whitman would doubt the firm’s ability to compete efficiently.
110.84%
Net income growth under 50% of AR's 432.14%. Michael Burry would suspect the firm is falling well behind a key competitor.
112.16%
EPS growth under 50% of AR's 422.77%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
111.56%
Diluted EPS growth under 50% of AR's 413.70%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.51%
Share reduction while AR is at 0.56%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.33%
Reduced diluted shares while AR is at 0.14%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-4.56%
Dividend reduction while AR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
44.87%
OCF growth at 50-75% of AR's 70.23%. Martin Whitman would question if the firm lags in monetizing sales effectively.
852.90%
Positive FCF growth while AR is negative. John Neff would see a strong competitive edge in net cash generation.
7.54%
10Y revenue/share CAGR under 50% of AR's 269.61%. Michael Burry would suspect a lasting competitive disadvantage.
-17.00%
Negative 5Y CAGR while AR stands at 0.35%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
75.71%
3Y revenue/share CAGR above 1.5x AR's 4.43%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
54.05%
10Y OCF/share CAGR above 1.5x AR's 33.67%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
64.42%
Positive OCF/share growth while AR is negative. John Neff might see a comparative advantage in operational cash viability.
73.68%
3Y OCF/share CAGR above 1.5x AR's 14.29%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
284.93%
Net income/share CAGR above 1.5x AR's 136.89% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
-41.80%
Negative 5Y net income/share CAGR while AR is 180.35%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
232.64%
3Y net income/share CAGR above 1.5x AR's 20.79%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
9.25%
Below 50% of AR's 68.43%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-2.49%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
157.13%
3Y equity/share CAGR above 1.5x AR's 7.74%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
8.84%
Dividend/share CAGR of 8.84% while AR is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
321.64%
Dividend/share CAGR of 321.64% while AR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
210.30%
3Y dividend/share CAGR of 210.30% while AR is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-11.98%
Firm’s AR is declining while AR shows 8.07%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
0.44%
Asset growth well under 50% of AR's 7.93%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
9.12%
BV/share growth above 1.5x AR's 1.07%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-5.59%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-80.31%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.